Production (Stage)
CalciMedica, Inc.
CALC
$1.75
$0.052.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -3,978.46% | -2.70% | -21.63% | 37.28% | 100.67% |
Total Depreciation and Amortization | 0.00% | -26.32% | 25.00% | 0.00% | 15.38% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 72.45% | -920.69% | 61.76% | -595.61% | -156.57% |
Change in Net Operating Assets | 460.94% | -27.73% | 137.73% | 87.01% | -105.07% |
Cash from Operations | -3.46% | -37.65% | -2.10% | 44.29% | 11.95% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 90.58% | -92.94% | 397.62% | -48.12% | -375.85% |
Cash from Investing | 90.51% | -93.01% | 397.42% | -47.70% | -375.85% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -94.87% | 5,027.59% | -77.78% | -- | 84.17% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -43.59% | 4,998.29% | -77.78% | 99.76% | -19.02% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 277.22% | 80.09% | 155.05% | 67.96% | -94.65% |